Starpharma’s cancer drug development platform has attracted the attention of UK pharmaceutical giant AstraZeneca. AstraZeneca has signed an agreement giving it the right to test some Starpharma oncology molecules based on its dendrimer molecule nanotechnology platform.
Australian Life Scientist